Skip to main content

Connor, Clark & Lunn Investment Management Ltd.

Position in MYGN — Myriad Genetics Inc

CIK 1596800 VANCOUVER, A1

Position in MYGN

as of Mar 31, 2026 · filed May 11, 2026
Position Value
$5,933,983
-$1,179,672 QoQ
Shares Held
1,318,663
+14.0% QoQ
Ownership
1.40%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2020
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MYGN Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

Connor, Clark & Lunn Investment Management Ltd. holds $199,549,511 across 18 Diagnostics & Research names. MYGN ranks #9 (3.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in MYGN

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $5,933,983 1,318,663
2025-12-31 $7,113,655 1,156,692
2025-09-30 $9,230,815 1,276,738
2025-06-30 $7,369,387 1,387,832
2025-03-31 $8,177,350 921,911
2024-12-31 $7,533,041 549,456
2024-09-30 $3,150,836 115,036
2024-06-30 $534,817 21,865
2023-12-31 $1,174,372 61,357
2023-09-30 $2,185,834 136,274
2023-06-30 $2,774,298 119,685
2023-03-31 $1,404,090 60,443
2022-12-31 $160,117 11,035
2020-12-31 $878,618 44,442
2020-09-30 $1,101,410 84,464